Exclusive-Drugmakers raise US prices on 350 drugs despite pressure from Trump
By Michael Erman NEW YORK, Dec 31 (Reuters) – Drugmakers plan to raise U.S. prices on at least 350 brand-name drugs including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively by health research firm 3 Axis Advisors. The … Read more
